Eurofins CDMO Alphora Inc., operating as part of Eurofins CDMO, provides integrated outsourcing solutions for drug substance / API, drug product, biologics and phytocannabinoids as a campus style facility based in North America. Specializing in complex and niche small molecule drug substance and drug product services, including high potent capabilities, we provide support from preclinical to commercial development & manufacturing. In biologics, our expertise lies in the development and scaling of monoclonal antibodies (mAbs) and other mammalian-based therapeutic proteins. Our offerings include upstream & downstream development, analytical services, antibody drug conjugate (ADC) capabilities, and scale-up capacity to 200L for pre-clinical and phase I supply. Additionally, we specialize in producing pharmaceutical-grade, high-quality phytocannabinoids via synthetic routes and reference standards.

Core Services:
Route Scouting
Route synthesis
Flow chemistry
High Potent Development & Manufacturing
Solid State R&D
Pre-formulation and Formulation Development
Fast Track Programs
Upstream & Downstream Processing Development
mAbs, ADCs Development